Principal Scientist, Precision Medicine Pathology

Principle Scientist, Precision Medicine Pathology

ABOUT THE COMPANY:

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 30,000 people worldwide and markets medicines in more than 170 countries.

General Position Summary/Purpose:

We are seeking a highly motivated individual to work within the Precision Medicine Pathology Group to design and implement novel tissue-based diagnostic assays to support the development and commercialization of medically-differentiated therapies in oncology and other therapeutic areas.  This position will develop and validate tissue-based assays to support discovery, translational and CDx work across therapeutic areas. He/she will also be involved in the development of next generation tissue-based assays in the areas of multiplexing, image analysis, and spatial profiling. The successful candidate will have the opportunity to work in a highly collaborative environment and will participate as a member of multidisciplinary, cross-functional development project teams.

Key Responsibilities

• Independently designs, validates, and implements novel tissue-based diagnostic assays for individual projects and/or therapeutic areas with a key responsibility to ensure delivery of highly specific and robust assays to meet project timelines
• Supports the general pathology needs of project teams through the effective design and execution of hypothesis-driven studies utilizing tissue based assays